Dobrin Nedelkov, Director of R&D at Intrinsic Bioprobes, On Proteomics | GenomeWeb

At A Glance

Name: Dobrin Nedelkov

Age: 35

Position: Director of research and technology development, Intrinsic Bioprobes, since 1999.

Background: Postdoc, Ken Williams’ laboratory, department of molecular biophysics and biochemistry, Yale University, 1998-1999.

PhD in biochemistry from Arizona State University, 1997.

 

You joined Intrinsic Bioprobes in 1999. What work did you do before joining Intrinsic Bioprobes?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.